Image

Global Stroke Diagnostics Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Oct 2021
  • Global
  • 350 Pages
  • No of Tables: 331
  • No of Figures: 73

Global Stroke Diagnostics Market, By Severity (Moderate, Severe, Mild), Type (Computed Tomography (CT Scan), Computed Tomography Angiography (CTA), Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA), Transcranial Doppler Ultrasound, Video Head Impulse Test (VHIT), Others), Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attacks (TIAS)), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare), Distribution Channel ( Direct Tender, Third Party Distributors, Others), Stage (Pre Operative, Peri Operative, Post Operative), Country (U.S., Canada, Mexico, Germany,  France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Austria, Belgium, Rest Of Europe, Japan, China, India, South Korea,  Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest Of Asia-Pacific, Brazil, Rest Of South America, South Africa, Saudi Arab, Rest Of Middle East and Africa) Industry Trends and Forecast to 2028

Stroke Diagnostics MarketMarket Analysis and Insights: Global Stroke Diagnostics Market

The stroke diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 5,465.11 million by 2028 from USD 3,143.34 million in 2020.

A stroke occurs when the supply of blood to the brain is decreased or blocked completely, which prevents the brain tissue from getting oxygen and nutrients. There are various types of diagnostics devices that are being used to detect stroke and its early symptoms, for instance, computed tomography (CT SCAN), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound and others.

The increasing incidence of stroke and cardiovascular and neurological disease has increased the demand for stroke diagnostics in developing countries. Also, the rise in healthcare expenditure is propelling market growth. On the other hand, the high cost of diagnosis may hinder market growth. The presence of market players and new product launches is providing an opportunity. However, the lack of skilled professionals may challenge the market.

The stroke diagnostics market report provides details of market share, new developments, the impact of domestic and localized market players, analysis of opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Stroke Diagnostics MarketGlobal Stroke Diagnostics Market Scope and Market Size

The global stroke diagnostics market is categorized into six notable segments which are based on the severity, type, application, end user, distribution channel, and stage.

  • On the basis of severity, the stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with an increase in the incidence rate of stroke globally.
  • On the basis of type, the stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the stroke diagnostics market with the increasing enhancement in the technology which provides accurate results.
  • On the basis of application, the stroke diagnostics market is segmented into an ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the stroke diagnostics market with the increasing incidence of ischemic stroke and advancement in technology.
  • On the basis of end-users, the stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the stroke diagnostics market due to the growing demand for stroke diagnostics.
  • On the basis of distribution channel, the stroke diagnostics market is segmented into direct tender, third-party distributor, and others. In 2021, direct tender is expected to dominate the stroke diagnostics market due growing healthcare infrastructure.
  • On the basis of stage, the stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the stroke diagnostics market due to the increasing incidence of cardiovascular surgeries.

Stroke Diagnostics MarketStroke Diagnostics Market Country Level Analysis

The stroke diagnostics market is analyzed, and market size information is provided into six notable segments, which are severity, type, application, end user, distribution channel, and stage.

The countries covered in the stroke diagnostics market report are the U.S., Canada, Mexico, Germany,  France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Austria, Belgium, rest of Europe, Japan, China, India, South Korea,  Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, rest of South America, South Africa, Saudi Arab, rest of the Middle East and Africa.

North America is expected to dominate the global stroke diagnostics market due to the presence of the largest consumer market with high GDP. The U.S. is expected to dominate the stroke diagnostics market due to an increase in technological advancement and stroke incidences. In Europe, Germany is expected to grow with the most promising growth rate in the forecast period of 2020 to 2028 due to an increase in R&D activities. Japan is expected to dominate in the stroke diagnostics market in the Asia-Pacific region as it is one of the leading countries in the world with rapidly increasing product usage and advancement in product development for stroke diagnostics.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Manufactures in Creating New Opportunities for Players in the Stroke diagnostics Market 

The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the healthcare industry with stroke diagnostics product sales, the impact of advancement in stroke diagnostics, and changes in regulatory scenarios with their support for the stroke diagnostics market. The data is available for the historical period 2010 to 2019.  

Competitive Landscape and Stroke diagnostics Market Share Analysis

Stroke diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.

The major companies providing stroke diagnostics are Siemens, Koninklijke Philips N.V., General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Canon Inc., ALPINION MEDICAL SYSTEMS Co., Ltd, Analogic Corporation, Aspect Imaging Ltd, BPL Medical Technologies, Carestream Health, ESAOTE SPA, FONAR Corp., Hologic, Inc., IMRIS, Deerfield Imaging Inc., Medfield Diagnostics AB, MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SIUI, SternMed GmbH, Stryker, among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.

For instances, 

  • In May 2021, Siemens announced that they are launching the new Somatom X.ceed1, a new high-resolution, high-speed CT (computed tomography) scanner engineered specifically for the most challenging clinical areas. It has provided the company with an increase in its product pipeline
  • In April 2021, Koninklijke Philips N.V announced their strategic partnership with Ibex Medical Analytics to jointly promote their digital pathology and A.I. solutions to hospitals, health networks, and pathology labs worldwide. It will increase their distribution channel globally

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the stroke diagnostics market, which also provides the benefit for the organization to improve their offering for the stroke diagnostics market.  

Customization Available: Global Stroke Diagnostics Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.  


SKU-

TABLE 1 GLOBAL STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 2 GLOBAL MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 GLOBAL SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 GLOBAL MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 GLOBAL STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 GLOBAL COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 GLOBAL COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 45 U.S. STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 46 U.S. STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 U.S. OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 U.S. STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 U.S. ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 U.S. HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 U.S. STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 U.S. STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 U.S. STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 54 CANADA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 55 CANADA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 CANADA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 57 CANADA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 CANADA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 CANADA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 CANADA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 61 CANADA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 CANADA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 63 MEXICO STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 64 MEXICO STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 MEXICO OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 MEXICO STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 MEXICO ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 68 MEXICO HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 69 MEXICO STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 MEXICO STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 MEXICO STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 72 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 73 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 74 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 SOUTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 SOUTH AMERICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 78 SOUTH AMERICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 79 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 82 BRAZIL STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 83 BRAZIL STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 BRAZIL OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 BRAZIL STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 BRAZIL ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 BRAZIL HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 88 BRAZIL STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 89 BRAZIL STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 90 BRAZIL STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 91 REST OF SOUTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 95 MIDDLE EAST AND AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 MIDDLE EAST AND AFRICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 98 MIDDLE EAST AND AFRICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 99 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 102 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 103 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 SAUDI ARABIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 106 SAUDI ARABIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 SAUDI ARABIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 109 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 110 SAUDI ARABIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 111 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 112 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 113 SOUTH AFRICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 115 SOUTH AFRICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 116 SOUTH AFRICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 SOUTH AFRICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 120 REST OF MIDDLE EAST AND AFRICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 121 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 122 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 123 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 124 ASIA-PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 125 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 126 ASIA-PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 ASIA-PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 128 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 129 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 130 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 131 JAPAN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 132 JAPAN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 JAPAN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 JAPAN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 135 JAPAN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 136 JAPAN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 137 JAPAN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 138 JAPAN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 139 JAPAN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 140 CHINA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 141 CHINA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 142 CHINA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 143 CHINA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 144 CHINA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 145 CHINA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 CHINA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 147 CHINA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 148 CHINA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 149 INDIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 150 INDIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 151 INDIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 INDIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 153 INDIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 154 INDIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 155 INDIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 156 INDIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 157 INDIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 158 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 159 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 SOUTH KOREA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 161 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 162 SOUTH KOREA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 163 SOUTH KOREA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 164 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 165 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 166 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 167 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 168 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 169 AUSTRALIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 171 AUSTRALIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 172 AUSTRALIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 173 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 174 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 175 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 176 SINGAPORE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 177 SINGAPORE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 178 SINGAPORE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 179 SINGAPORE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 180 SINGAPORE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 SINGAPORE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 182 SINGAPORE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 183 SINGAPORE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 184 SINGAPORE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 185 THAILAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 186 THAILAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 187 THAILAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 188 THAILAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 189 THAILAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 190 THAILAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 191 THAILAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 192 THAILAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 193 THAILAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 194 MALAYSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 195 MALAYSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 MALAYSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 MALAYSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 198 MALAYSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 199 MALAYSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 200 MALAYSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 201 MALAYSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 202 MALAYSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 203 INDONESIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 204 INDONESIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 205 INDONESIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 206 INDONESIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 207 INDONESIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 208 INDONESIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 209 INDONESIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 210 INDONESIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 211 INDONESIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 212 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 213 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 214 PHILIPPINES OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 215 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 216 PHILIPPINES ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 217 PHILIPPINES HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 218 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 219 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 220 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 221 REST OF ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 222 EUROPE STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 223 EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 224 EUROPE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 225 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 226 EUROPE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 227 EUROPE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 228 EUROPE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 229 EUROPE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 230 EUROPE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 231 EUROPE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 232 GERMANY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 233 GERMANY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 234 GERMANY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 235 GERMANY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 236 GERMANY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 237 GERMANY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 238 GERMANY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 239 GERMANY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 240 GERMANY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 241 FRANCE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 242 FRANCE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 243 FRANCE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 244 FRANCE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 245 FRANCE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 246 FRANCE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 247 FRANCE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 248 FRANCE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 249 FRANCE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 250 U.K. STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 251 U.K. STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 252 U.K. OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 253 U.K. STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 254 U.K. ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 255 U.K. HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 256 U.K. STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 257 U.K. STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 258 U.K. STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 259 ITALY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 260 ITALY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 261 ITALY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 262 ITALY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 263 ITALY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 264 ITALY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 265 ITALY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 266 ITALY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 267 ITALY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 268 SPAIN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 269 SPAIN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 270 SPAIN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 271 SPAIN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 272 SPAIN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 273 SPAIN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 274 SPAIN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 275 SPAIN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 276 SPAIN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 277 RUSSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 278 RUSSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 279 RUSSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 280 RUSSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 281 RUSSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 282 RUSSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 283 RUSSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 284 RUSSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 285 RUSSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 286 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 287 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 288 NETHERLANDS OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 289 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 290 NETHERLANDS ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 291 NETHERLANDS HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 292 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 293 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 294 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 295 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 296 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 297 SWITZERLAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 298 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 299 SWITZERLAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 300 SWITZERLAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 301 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 302 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 303 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 304 TURKEY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 305 TURKEY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 306 TURKEY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 307 TURKEY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 308 TURKEY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 309 TURKEY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 310 TURKEY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 311 TURKEY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 312 TURKEY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 313 AUSTRIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 314 AUSTRIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 315 AUSTRIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 316 AUSTRIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 317 AUSTRIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 318 AUSTRIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 319 AUSTRIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 320 AUSTRIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 321 AUSTRIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 322 BELGIUM STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 323 BELGIUM STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 324 BELGIUM OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 325 BELGIUM STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 326 BELGIUM ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 327 BELGIUM HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 328 BELGIUM STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 329 BELGIUM STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 330 BELGIUM STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 331 REST OF EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions